These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 10924575)
41. [Chemoembolization of the hepatic artery in the treatment of primary and metastatic liver cancer]. Granov AM; Tarazov PG; Granov DA Vestn Rentgenol Radiol; 1996; (2):34-8. PubMed ID: 8754120 [TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan. Shiroiwa T; Fukuda T; Tsutani K Clin Ther; 2007 Oct; 29(10):2256-67. PubMed ID: 18042483 [TBL] [Abstract][Full Text] [Related]
43. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [TBL] [Abstract][Full Text] [Related]
44. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533 [TBL] [Abstract][Full Text] [Related]
45. Colorectal metastases to the liver: selective chemoembolization. Lang EK; Brown CL Radiology; 1993 Nov; 189(2):417-22. PubMed ID: 8210369 [TBL] [Abstract][Full Text] [Related]
46. Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications. Berger DH; Carrasco CH; Hohn DC; Curley SA J Surg Oncol; 1995 Oct; 60(2):116-21. PubMed ID: 7564377 [TBL] [Abstract][Full Text] [Related]
47. Combination treatment of CC531-lac-Z rat liver metastases by chemoembolization with pemetrexed disodium and gemcitabine. Rodenbach M; Eyol E; Seelig MH; Berger MR J Cancer Res Clin Oncol; 2005 May; 131(5):289-99. PubMed ID: 15657768 [TBL] [Abstract][Full Text] [Related]
48. Laparoscopic debridement of hepatic necrosis after hepatic artery chemoembolization. Tejirian T; Heaney A; Colquhoun S; Nissen N JSLS; 2007; 11(4):493-5. PubMed ID: 18237517 [TBL] [Abstract][Full Text] [Related]
49. Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization. Dayani PN; Gould JE; Brown DB; Sharma KV; Linette GP; Harbour JW Arch Ophthalmol; 2009 May; 127(5):628-32. PubMed ID: 19433711 [TBL] [Abstract][Full Text] [Related]
50. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Drougas JG; Anthony LB; Blair TK; Lopez RR; Wright JK; Chapman WC; Webb L; Mazer M; Meranze S; Pinson CW Am J Surg; 1998 May; 175(5):408-12. PubMed ID: 9600289 [TBL] [Abstract][Full Text] [Related]
51. Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned. Bloomston M; Al-Saif O; Klemanski D; Pinzone JJ; Martin EW; Palmer B; Guy G; Khabiri H; Ellison EC; Shah MH J Gastrointest Surg; 2007 Mar; 11(3):264-71. PubMed ID: 17458596 [TBL] [Abstract][Full Text] [Related]
52. Cost-utility analysis of operative versus non-operative treatment for colorectal liver metastases. Roberts KJ; Sutton AJ; Prasad KR; Toogood GJ; Lodge JP Br J Surg; 2015 Mar; 102(4):388-98. PubMed ID: 25624168 [TBL] [Abstract][Full Text] [Related]
53. Cost Accounting as a Tool for Increasing Cost Transparency in Selective Hepatic Transarterial Chemoembolization. Ahmed O; Patel M; Ward T; Sze DY; Telischak K; Kothary N; Hofmann LV J Vasc Interv Radiol; 2015 Dec; 26(12):1820-6.e1. PubMed ID: 26521766 [TBL] [Abstract][Full Text] [Related]
54. Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols. Vogl TJ; Gruber T; Naguib NN; Hammerstingl R; Nour-Eldin NE AJR Am J Roentgenol; 2009 Oct; 193(4):941-7. PubMed ID: 19770314 [TBL] [Abstract][Full Text] [Related]
55. Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases. Meta-Analysis Group In Cancer. Durand-Zaleski I; Roche B; Buyse M; Carlson R; O'Connell M; Rougier P; Chang AE; Sondak VK; Kemeny M; Allen-Mersh T; Fagniez PL; Le Bourgeois JP; Piedbois P Crit Rev Oncol Hematol; 1999 Nov; 32(2):125-31. PubMed ID: 10612012 [No Abstract] [Full Text] [Related]
56. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors. Ruszniewski P; Malka D Digestion; 2000; 62 Suppl 1():79-83. PubMed ID: 10940692 [TBL] [Abstract][Full Text] [Related]
57. Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors. Desai DC; O'Dorisio TM; Schirmer WJ; Jung SS; Khabiri H; Villanueva V; Martin EW Regul Pept; 2001 Jan; 96(3):113-7. PubMed ID: 11111016 [TBL] [Abstract][Full Text] [Related]